Literature DB >> 35596779

Quantitative water T2 relaxometry in the early detection of neuromuscular diseases: a retrospective biopsy-controlled analysis.

Noah Locher1, Benedikt Wagner2, Fabian Balsiger1,2, Olivier Scheidegger3,4,5.   

Abstract

OBJECTIVES: To assess quantitative water T2 relaxometry for the early detection of neuromuscular diseases (NMDs) in comparison to standard qualitative MR imaging in a clinical setting.
METHODS: This retrospective study included 83 patients with suspected NMD who underwent multiparametric MRI at 3 T with a subsequent muscle biopsy between 2015 and 2019. Qualitative T1-weighted and T2-TIRM images were graded by two neuroradiologists to be either pathological or normal. Mean and median water T2 relaxation times (water T2) were obtained from manually drawn volumes of interests in biopsied muscle from multi-echo sequence. Histopathologic pattern of corresponding muscle biopsies was used as a reference.
RESULTS: In 34 patients, the T1-weighted images showed clear pathological alternations indicating late-stage fatty infiltration in NMDs. In the remaining 49 patients without late-stage changes, T2-TIRM grading achieved a sensitivity of 56.4%, and mean and median water T2 a sensitivity of 87.2% and 97.4% to detect early-stage NMDs. Receiver operating characteristic (ROC) analysis revealed an area under the curve (AUC) of 0.682, 0.715, and 0.803 for T2-TIRM, mean water T2, and median water T2, respectively. Median water T2 ranged between 36 and 42 ms depending on histopathologic pattern.
CONCLUSIONS: Quantitative water T2 relaxometry had a significantly higher sensitivity in detecting muscle abnormalities than subjective grading of T2-TIRM, prior to late-stage fatty infiltration signal alternations in T1-weighted images. Normal-appearing T2-TIRM does not rule out early-stage NMDs. Our findings suggest considering water T2 relaxometry complementary to T2-TIRM for early detection of NMDs in clinical diagnostic routine. KEY POINTS: • Quantitative water T2 relaxometry is more sensitive than subjective assessment of fat-suppressed T2-weighted images for the early detection of neuromuscular diseases, prior to late-stage fatty infiltration signal alternations in T1-weighted images. • Normal-appearing muscles in fat-suppressed T2-weighted images do not rule out early-stage neuromuscular diseases. • Quantitative water T2 relaxometry should be considered complementary to subjectively rated fat-suppressed T2-weighted images in clinical practice.
© 2022. The Author(s).

Entities:  

Keywords:  Biopsy; Magnetic resonance imaging; Muscles; Neuromuscular diseases; Water T2 relaxation time, fat-suppressed T2-weighted MRI

Year:  2022        PMID: 35596779     DOI: 10.1007/s00330-022-08862-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

Review 1.  MRI in Neuromuscular Diseases: An Emerging Diagnostic Tool and Biomarker for Prognosis and Efficacy.

Authors:  Julia R Dahlqvist; Per Widholm; Olof Dahlqvist Leinhard; John Vissing
Journal:  Ann Neurol       Date:  2020-07-01       Impact factor: 10.422

2.  A short protocol for muscle MRI in children with muscular dystrophies.

Authors:  Eugenio Mercuri; Anna Pichiecchio; Serena Counsell; Joanna Allsop; Claudio Cini; Heinz Jungbluth; Carla Uggetti; Graeme Bydder
Journal:  Eur J Paediatr Neurol       Date:  2002       Impact factor: 3.140

3.  Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: different methodology, different information and different implications.

Authors:  Pierre G Carlier
Journal:  Neuromuscul Disord       Date:  2014-02-28       Impact factor: 4.296

Review 4.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

5.  Skeletal muscle water T2 as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy.

Authors:  Ami Mankodi; Noura Azzabou; Thomas Bulea; Harmen Reyngoudt; Hirity Shimellis; Yupeng Ren; Eunhee Kim; Kenneth H Fischbeck; Pierre G Carlier
Journal:  Neuromuscul Disord       Date:  2017-04-28       Impact factor: 4.296

Review 6.  MRI scoring methods used in evaluation of muscle involvement in patients with idiopathic inflammatory myopathies.

Authors:  Kateřina Kubínová; Heřman Mann; Jiří Vencovský
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

7.  Distinct muscle imaging patterns in myofibrillar myopathies.

Authors:  D Fischer; R A Kley; K Strach; C Meyer; T Sommer; K Eger; A Rolfs; W Meyer; A Pou; J Pradas; C M Heyer; A Grossmann; A Huebner; W Kress; J Reimann; R Schröder; B Eymard; M Fardeau; B Udd; L Goldfarb; M Vorgerd; M Olivé
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

8.  Quantitative MRI in muscular dystrophy: An indispensable trial endpoint?

Authors:  Kieren G Hollingsworth
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

9.  Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients.

Authors:  Pierre G Carlier; Noura Azzabou; Paulo Loureiro de Sousa; Arnaud Hicks; Jean-Marc Boisserie; Alexis Amadon; Robert-Yves Carlier; Claire Wary; David Orlikowski; Pascal Laforêt
Journal:  J Inherit Metab Dis       Date:  2015-03-07       Impact factor: 4.982

Review 10.  Advances in Quantitative Imaging of Genetic and Acquired Myopathies: Clinical Applications and Perspectives.

Authors:  Matteo Paoletti; Anna Pichiecchio; Stefano Cotti Piccinelli; Giorgio Tasca; Angela L Berardinelli; Alessandro Padovani; Massimiliano Filosto
Journal:  Front Neurol       Date:  2019-02-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.